The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density

NCT04630964 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder
Depression

Interventions

DRUG: Psilocybin
DRUG: Niacin

Sponsor

Section for Affective Disorders; Northern Stockholm Psychiatry

Collaborators

[object Object]